A rip current statement was released by the National Weather Service on Friday at 2:08 a.m. in effect until 7 p.m. for Bristol, Plymouth and Barnstable counties.

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced ...

PANOVA-3: Phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma (LA-PAC).. If you have the appropriate software ...

The first phase of Honkai Star Rail 3.3 is nearing its end, and Trailblazers are eagerly waiting for the upcoming 5-star unit, Cipher.

BAAR, Switzerland, May 31, 2025--Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented ...

In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...

In the Phase 3 AFFIRM-AL clinical trial, the primary endpoint of time to all-cause mortality was not met for patients treated with birtamimab.

Wuthering Waves 2.3 update is all heated with the coming Phase 2 updates, bringing fresh characters, weapons and some limited-time events. The players can even look forward to the fresh banners ...

In every patch, HoYoverse introduces several new events, and the upcoming Honkai Star Rail 3.3 update isn't an exception.

Aardvark Therapeutics, Inc. announced progress in its Phase 3 HERO trial for ARD-101, aimed at treating hyperphagia associated with Prader-Willi Syndrome, with data expected in early 2026.

Enrollment in CHAPTER-3, a Phase 3 study of deucrictibant for prophylaxis of HAE attacks, is progressing as planned, indicating ongoing commitment to advancing clinical development.